ArticleBone reports2019

Bruton's tyrosine kinase (Btk) inhibitor tirabrutinib suppresses osteoclastic bone resorption.

Yuko Ariza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.